| Mitochondrial-based therapeutics for the treatment of spinal cord injury: mitochondrial biogenesis as a potential pharmacological target NE Scholpa, RG Schnellmann Journal of Pharmacology and Experimental Therapeutics 363 (3), 303-313, 2017 | 123 | 2017 |
| Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases EC Simmons, NE Scholpa, RG Schnellmann Experimental neurology 329, 113309, 2020 | 95 | 2020 |
| Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β2-Adrenoreceptor Agonist Formoterol for the … NE Scholpa, H Williams, W Wang, D Corum, A Narang, S Tomlinson, ... Journal of neurotrauma 36 (6), 962-972, 2019 | 50 | 2019 |
| 5‐HT1F receptor‐mediated mitochondrial biogenesis for the treatment of Parkinson's disease NE Scholpa, MK Lynn, D Corum, HA Boger, RG Schnellmann British journal of pharmacology 175 (2), 348-358, 2018 | 43 | 2018 |
| 5-hydroxytryptamine 1F receptor agonist induces mitochondrial biogenesis and promotes recovery from spinal cord injury EC Simmons, NE Scholpa, KH Cleveland, RG Schnellmann Journal of Pharmacology and Experimental Therapeutics 372 (2), 216-223, 2020 | 34 | 2020 |
| β2-adrenergic receptor-mediated mitochondrial biogenesis improves skeletal muscle recovery following spinal cord injury NE Scholpa, EC Simmons, DG Tilley, RG Schnellmann Experimental neurology 322, 113064, 2019 | 32 | 2019 |
| Role of the Phospholipase A2 Receptor in Liposome Drug Delivery in Prostate Cancer Cells ND Quach, JN Mock, NE Scholpa, MW Eggert, C Payré, G Lambeau, ... Molecular pharmaceutics 11 (10), 3443-3451, 2014 | 32 | 2014 |
| Formoterol, a β2-adrenoreceptor agonist, induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury HJ Vekaria, WB Hubbard, NE Scholpa, ML Spry, JL Gooch, SJ Prince, ... Neurobiology of disease 140, 104866, 2020 | 29 | 2020 |
| FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury EC Simmons, NE Scholpa, RG Schnellmann Experimental neurology 341, 113720, 2021 | 26 | 2021 |
| Differential effects of cocaine exposure on the abundance of phospholipid species in rat brain and blood BS Cummings, S Pati, S Sahin, NE Scholpa, P Monian, PM Trinquero, ... Drug and alcohol dependence 152, 147-156, 2015 | 23 | 2015 |
| Time-to-treatment window and cross-sex potential of β2-adrenergic receptor-induced mitochondrial biogenesis-mediated recovery after spinal cord injury NE Scholpa, EC Simmons, JD Crossman, RG Schnellmann Toxicology and Applied Pharmacology 411, 115366, 2021 | 21 | 2021 |
| ERK oscillation-dependent gene expression patterns and deregulation by stress response KM Waters, BS Cummings, H Shankaran, NE Scholpa, TJ Weber Chemical Research in Toxicology 27 (9), 1496-1503, 2014 | 18 | 2014 |
| Epigenetic changes in p21 expression in renal cells after exposure to bromate NE Scholpa, X Zhang, RT Kolli, BS Cummings Toxicological Sciences 141 (2), 432-440, 2014 | 17 | 2014 |
| Cyclin-dependent kinase inhibitor 1a (p21) modulates response to cocaine and motivated behaviors NE Scholpa, SB Briggs, JJ Wagner, BS Cummings Journal of Pharmacology and Experimental Therapeutics 357 (1), 56-65, 2016 | 13 | 2016 |
| Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer NE Scholpa, RT Kolli, M Moore, RD Arnold, TC Glenn, BS Cummings Chemico-biological interactions 258, 21-29, 2016 | 9 | 2016 |
| Serotonin regulation of mitochondria in kidney diseases K Hurtado, NE Scholpa, JG Schnellmann, RG Schnellmann Pharmacological Research, 107154, 2024 | 5 | 2024 |
| Pharmacological stimulation of mitochondrial biogenesis using the FDA-approved beta2-adrenoreceptor agonist formoterol for the treatment of spinal cord injury NE Scholpa, H Williams, W Wang, D Corum, A Narang, S Tomlinson, ... J Neurotrauma, 2018 | 5 | 2018 |
| Role of DNA methylation during recovery from spinal cord injury with and without β2-adrenergic receptor agonism NE Scholpa Experimental Neurology 368, 114494, 2023 | 4 | 2023 |
| Pharmacological activation of mitochondrial biogenesis for the treatment of various pathologies WS Gibbs, NE Scholpa, CC Beeson, RG Schnellmann Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants, 569-592, 2018 | 3 | 2018 |
| Boosting Mitochondrial Biogenesis Diminishes Foam Cell Formation in the Post-Stroke Brain SH Loppi, MA Tavera-Garcia, NE Scholpa, BK Maiyo, DA Becktel, ... International Journal of Molecular Sciences 24 (23), 16632, 2023 | 2 | 2023 |
